Implication of RANTES in the modulation of alloimmune response by progesterone during pregnancy

American Journal of Reproductive Immunology

Volumn 57, Issue 2, 2007, Pages 147-152

  Ramhorst, Rosanna ^a   Gutiérrez, Gabriela ^b   Corigliano, Adriana ^a   Junovich, G ^b   Fainboim, Leonardo ^a  

^a HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Abortion; Pregnancy; Progesterone; RANTES

Indexed keywords

ALLOANTIGEN; PROGESTERONE; RANTES;

ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; FEMALE; FETOPLACENTAL UNIT; FETUS RESORPTION; IMMUNOMODULATION; IN VITRO STUDY; MOUSE; MULTIPARA; NONHUMAN; NULLIPARA; PREGNANCY; PRIMIPARA; PRIORITY JOURNAL; PROGESTERONE SYNTHESIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SPONTANEOUS ABORTION;

ABORTION, SPONTANEOUS; ANIMALS; FEMALE; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; MICE, INBRED DBA; PLACENTA; PREGNANCY; PROGESTERONE; RANTES;

EID: 33846261461     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2006.00458.x     Document Type: Article

References (22)

1. Thellin O, Coumans B, Zorzi W, Igout A, Heinen E: Tolerance to the foeto-placental "graft": Ten ways to support a child for nine months. Curr Opin Immunol 2000; 12: 731-737.
2. Chaouat G, Zourbas S, Ostoij S, Lappree-Delage G, Dubanchet S, Ledee N, Matral J: A brief review of recent data on some cytokine expressions at the materno-fetal interface which might challenge the classical Th1/Th2 dichotomy. J Reprod Immunol 2002; 53: 241-253.
3. Wallach E: Chemokines and human reproduction. Fertil Steril 1999; 71: 983-993.
4. Hournung D, Bentzein F, Wallwiener D, Kiesel D, Taylor RN: Chemokine bioactivity of RANTES in endometriotic and normal stromal cells and peritoneal fluid. Mol Hum Reprod 2001; 7: 163-168.
5. Zhao D, Lebovic D, Taylor RN: Long term progestin treatment inhibits RANTES (Regulated on activation, normal T cell expressed and secreted) gene expression in human endometrial stromal cells. J Clin Endocrinol Metabol 2002; 87: 2514-2519.
6. Von Hundelshausen P, Koenen RR, Sack M, Mause SF, Adriaens W, Proudfoot AE, Hackeng TM, Weber C: Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium. Blood 2005; 105: 924-930.
7. Thirkill TL, Lowe K, Vedagiri H, Blankenship TN, Barakat A, Douglas G: Macaque trophoblast migration is regulated by RANTES. Exp Cell Res 2005; 305: 355-364.
8. Muciaccia B, Padula F, Vicini E, Gandini L, Lenzi A, Stefanini M: Beta-chemokine receptors 5 and 3 are expressed on the head region of human spermatozoon. FASEB J 2005; 19: 2048-2050.
9. Ramhorst R, García V, Corigliano A, Rabinovich G, Fainboim L: Identification of RANTES as a novel immunomodulator of the maternal allogeneic response. Clin Immunol 2004; 110: 71-80.
10. Khorram O, Taylor RN, Ryan IP, Schall TJ, Landers DV: Peritoneal fluid concentration of the cytokine RANTES correlate with the severy of endometriosis. Am J Obstet Gynecol 1993; 169: 1545-1549.
11. Hornung D, Bentzein F, Wallweiner D, Kiesel L, Taylor RN: Chemokine bioactivity of RANTES in endometriotic and normal endometrial stromal cells and peritoneal fluid. Mol Hum Reprod 2001; 7: 163-168.
12. Chaouat G, Zourbas S, Ostoij S, Lappree-Delage G, Dubanchet S, Ledee N, Matral J: A brief review of recent data on some cytokine expressions at the materno-fetal interface which might challenge the classical Th1/Th2 dichotomy. J Reprod Immunol 2002; 53: 241-256.
13. Chaouat G, Ledee-Bataille N, Dubanchet S, Zourbas S, Sandra O, Martal J: TH1/TH2 paradigm in pregnancy: Paradigm lost? Cytokines in pregnancy/ early abortion: Reexamining the TH1/TH2 paradigm. Int Arch Allergy Immunol 2004; 134: 93-119.
14. Saito S: Cytokine network at feto-maternal interface. J Reprod Immunol 2000; 47: 87-103.
15. Dosiou CH, Giudice L: Natural killer cells in pregnancy and recurrent pregnancy loss: Endocrine and immunological perspectives. Endocr Rev 2005; 26: 44-62.
16. Chaouat G, Menu E, Dy M, Minkowski M, Clark DA, Wegmann TG: Control of fetal survival in CBAxDBA/2 mice by lymphokine therapy. J Fertil Steril 1990; 89: 447-450.
17. Clark DA, Chaouat G,MGorczynski RM: Thinking outside the box: mechanisms of environmental selective pressures on the outcome of the materno-fetal relationship. Am J Reprod Immunol 2002; 47: 275-282.
18. Chavez DJ, McIntyre JA, Colliver JA, Faulk WP: Allogeneic matings and immunization have different effects on nulliparous and multiparous mice. J Immunol 1987; 139: 85-88.
19. Clark DA, Chaouat G, Arck PC, Mittruecker HW, Levy GA: Cytokine-dependent abortion in CBAxDBA/2 mice is mediated by the procoagulant fgl2 prothrombinase. J Immunol 1998; 15: 545-549.
20. Faunce D, Stein-Streilen: MIP-2 recruit NKT cells to the spleen during tolerance induction. J Immunol 2001; 166: 313-321.
21. Cui J, Shin T, Kawano H, Sato E, Kondo L, Toura Y, Kaneko H, Koseki M, Taniguchi M: Requirement for Valfa 4 NKT cells in IL-12 mediated rejection of tumors. Science 1997; 278: 1623-1626.
22. +T cells to the spleen during the generation of regulatory T cells in tolerance. J Immunol 2002; 169: 31-38.